Treatment | Page 297 of 465

Aphasia :: Genetic cause found for word-finding disease Aphasia

Northwestern University researchers have discovered a genetic cause of a mysterious neurological disease in which people have trouble recalling and using words. The illness, Primary Progressive Aphasia, differs from Alzheimer’s Disease in which a person’s memory becomes impaired. In PPA, which can begin in the 40’s and 50’s, people eventually lose the ability to express themselves and understand speech. Although people lose the ability to communicate, they are still able to perform complicated tasks.

Thrombosis :: A possible cause of thrombosis discovered

A team of researchers from the CIMA of the University of Navarra has discovered a possible cause of thrombosis, and has developed a new diagnostic test for this disease. The scientific project was undertaken in the Hemostasis and Thrombosis Laboratory.

Medicine :: Producing medicines in plant seeds

Using plants to produce useful proteins could be an inexpensive alternative to current medicine production methods. Researchers from VIB at Ghent University have succeeded in producing in plant seeds proteins that have a very strong resemblance to antibodies. They have also demonstrated that these antibody variants are just as active as the whole antibodies that occur naturally in humans. By virtue of their particular action, antibodies are very useful for therapeutic and diagnostic applications.

Brain Tumor :: New angiogenesis inhibitor has promise for treating deadly brain tumor

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have found that AZD2171 (RECENTIN(tm)), a new angiogenesis inhibitor, can significantly reduce the size of the deadly brain tumors called glioblastomas and has the potential of improving the effectiveness of other therapeutic techniques.

Cancer :: Small molecule offers big hope against cancer

Researchers at the University of Alberta have shown that a nontoxic molecule shrinks cancers tumors, including lung, breast and brain. The results of the research will be published in the journal Cancer Cell.

Prostate Cancer :: Sunshine pill for prostate cancer in 2009

A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.

Brain Tumor :: Brain tumors arise from cancer stem cells

Brain tumors appear to arise from cancer stem cells (CSCs) that live within microscopic protective “niches” formed by blood vessels in the brain; and disrupting these niches is a promising strategy for eliminating the tumors and preventing them from re-growing, according to results of a study by investigators at St. Jude Children’s Research Hospital. CSCs are cells that continually multiply, acting as the source of tumors.

Parenting :: First test tube baby becomes a mother

Louise Brown, the world’s first test tube baby, has given birth to a child of her own – a boy. 28-year-old Louise, an administrative assistant, and her husband Wesley Mullinder, 37, were delighted at the safe arrival of the baby.

Tuberculosis :: Growing Number of TB Cases Continuing Challenge for Thai Government

The increasing number of tuberculosis cases detected annually in Thailand is an ongoing challenge for the government, the Nation reports. According to Somchai Pinyopornpaitch, deputy director-general of the Department of Disease Control, TB cases have increased for several years despite health officials’ efforts.

HIV :: New genetic cause of an immunodeficiency syndrome found

A gene called HAX1 is mutated in some individuals with an immunodeficiency syndrome known as severe congenital neutropenia (SCN), according to a study to be published in the January issue of Nature Genetics. The identification of mutations in HAX1 ends a 50-year search for the genetic basis of one form of this disease.